Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts

Leukemia Research

Volumn 28, Issue 12, 2004, Pages 1303-1312

  Gong, Jianlin ^a   Koido, Shigeo ^a   Kato, Yoko ^a   Tanaka, Yasuhiro ^a   Chen, Dongshu ^a   Jonas, Anna ^a   Galinsky, Ilene ^a   Deangelo, Daniel ^a   Avigan, David ^a   Kufe, Donald ^a   Stone, Richard ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti leukemia immunity; Autologous T cell proliferation; Fusion of autologous DC and AML blasts; Generation of dendritic cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW; CANCER PATIENT; CELL ACTIVITY; CELL ADHESION; CELL FUNCTION; CELL FUSION; CELL POPULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MALE; MORPHOLOGY; MYELOBLAST; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW CELLS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL FUSION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GRANULOCYTE PRECURSOR CELLS; HUMANS; IMMUNOTHERAPY; LEUKEMIA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC;

EID: 4744346954     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.03.018     Document Type: Article

References (45)

1. Richman S.P., Gutterman J.U., Hersh E.M. Cancer immunotherapy. Can Med. Assoc. J. 120:1979;322-324
2. Bartlett G.L., Kreider J.W., Purnell D.M. Active specific immunotherapy of murine leukemia. Part I. Irradiated tumor cell vaccine. Int. J. Cancer. 24:1979;629-635
3. Porgador A., Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:1995;255-260
4. Macatonia S.E., Taylor P.M., Knight S.C., Askonas B.A. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169:1989;1255-1264
5. Bhardwaj N., Bender A., Gonzalez N., Bui L.K., Garrett M.C., Steinman R.M. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin Invest. 94:1994;797-807
6. Bjorck P. Development of dendritic cells and their use in tumor therapy. Clin Immunol. 92:1999;119-127
7. Inaba K., Witmer-Pack M., Inaba M., Hathcock K.S., Sakuta H., Azuma M., et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1994;1849-1860
8. Fong L., Engleman E.G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18:2000;245-273
9. Young J.W., Koulova L., Soergel S.A., Clark E.A., Steinman R.M., Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J. Clin Invest. 90:1992;229-237
10. Santiago-Schwarz F., Coppock D.L., Hindenburg A.A., Kern J. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood. 84:1994;3054-3062
11. Cignetti A., Bryant E., Allione B., Vitale A., Foa R., Cheever M.A. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood. 94:1999;2048-2055
12. Choudhury B.A., Liang J.C., Thomas E.K., Flores-Romo L., Xie Q.S., Agusala K., et al. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood. 93:1999;780-786
13. Choudhury A., Toubert A., Sutaria S., Charron D., Champlin R.E., Claxton D.F. Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. Crit. Rev. Immunol. 18:1998;121-131
14. Charbonnier A., Gaugler B., Sainty D., Lafage-Pochitaloff M., Olive D. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur. J. Immunol. 29:1999;2567-2578
15. Spisek R., Chevallier P., Morineau N., Milpied N., Avet-Loiseau H., Harousseau J.L., et al. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Cancer Res. 62:2002;2861-2868
16. Severson R.K., Ross J.A. The causes of acute leukemia. Curr. Opin. Oncol. 11:1999;20-24
17. Lowenberg B., Downing J.R., Burnett A. Acute myeloid leukemia. N Engl. J. Med. 341:1999;1051-1062
18. Steinman R.M., Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer. 94:2001;459-473
19. Ying H., Zaks T.Z., Wang R.F., Irvine K.R., Kammula U.S., Marincola F.M., et al. Cancer therapy using a self-replicating RNA vaccine. Nat. Med. 5:1999;823-827
20. Nair S.K., Boczkowski D., Morse M., Cumming R.I., Lyerly H.K., Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat. Biotechnol. 16:1998;364-369
21. Koido S., Kashiwaba M., Chen D., Gendler S., Kufe D., Gong J. Induction of anti-tumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J. Immunol. 165:2000;5713-5719
22. Mandl C.W., Aberle J.H., Aberle S.W., Holzmann H., Allison S.L., Heinz F.X. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat Med. 4:1998;1438-1440
23. Boczkowski D., Nair S.K., Snyder D., Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:1996;465-472
24. Celluzzi C.M., Mayordomo J.I., Storkus W.J., Lotze M.T., Falo L.D. Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:1996;283-287
25. Mayordomo J.I., Zorina T., Storkus W.J., Zitvogel L., Celluzzi C., Falo L.D., et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med. 1:1995;1297-1302
26. Paglia P., Chiodoni C., Rodolfo M., Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:1996;317-322
27. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:1998;328-332
28. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I - restricted CTLs. Nature. 392:1998;86-89
29. Gong J., Chen D., Kashiwaba M., Kufe D. Induction of anti-tumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med. 3:1997;558-561
30. Gong J., Chen D., Kashiwaba M., Li Y., Chen L., Takeuchi H., et al. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6279-6283
31. Celluzzi C.M., Falo L.D. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160:1998;3081-3085
32. Lespagnard L., Mettens P., Verheyden A.M., Tasiaux N., Thielemans K., van Meirvenne S., et al. Dendritic cells fused with mastocytoma cells elicit therapeutic anti-tumor immunity. Int. J. Cancer. 76:1998;250-258
33. Wang J., Saffold S., Cao X., Krauss J., Chen W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161:1998;5516-5524
34. Akasaki Y., Kikuchi T., Homma S., Abe T., Kofe D., Ohno T. Antitumor Effect of Immunizations With Fusions of Dendritic and Glioma Cells in a Mouse Brain Tumor Model. J. Immunother. 24:2001;106-113
35. Homma S., Toda G., Gong J., Kufe D., Ohno T. Preventive anti-tumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J. Gastroenterol. 36:2001;764-771
36. Kikuchi T., Akasaki Y., Irie M., Homma S., Abe T., Ohno T. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol. Immunother. 50:2001;337-344
37. Gong J., Avigan D., Chen D., Wu Z., Koido S., Kashiwaba M., et al. Activation of anti-tumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2715-2718
38. Gong J., Nikrui N., Chen D., Koido S., Wu Z., Tanaka Y., et al. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce anti-tumor immunity. J. Immunol. 165:2000;1705-1711
39. Trefzer U., Weingart G., Chen Y., Herberth G., Adrian K., Winter H., et al. Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int. J. Cancer. 85:2000;618-626
40. Galea-Lauri J., Darling D., Mufti G., Harrison P., Farzaneh F. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol. Immunother. 51:2002;299-310
41. Koido S., Tanaka Y., Chen D., Kufe D., Gong J. The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice. J. Immunol. 168:2002;2111-2117
42. Liu Y., Zhang W., Chan T., Saxena A., Xiang J. Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances anti-tumor immunity. Leuk. Res. 26:2002;757-763
43. Phan V., Errington F., Cheong S.C., Kottke T., Gough M., Altmann S., et al. A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nat. Med. 9:2003;1215-1219
44. Takeda A., Homma S., Okamoto T., Kufe D., Ohno T. Immature dendritic cell/tumor cell fusions induce potent antitumour immunity. Eur. J. Clin Invest. 33:2003;897-904
45. Biragyn A., Surenhu M., Yang D., Ruffini P.A., Haines B.A., Klyushnenkova E., et al. Mediators of innate immunity that target immature, but not mature, dendritic cells induce anti-tumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 167:2001;6644-6653